Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Analysis of healthcare records pertaining to the population of Germany.
The University wants to study the potential correlation between antiviral medication and later onset of Alzheimer disease. The study involves healthcare records in Scotland, Wales, and Germany. The German arm of the study is to be performed by IQVIA, Germany, a Human Data Science Company, that holds an extensive database and accompanying software, the IMS® Disease Analyzer, covering over 3 million patients in Germany.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| IQVIA Germany | - | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £95,000 initial term | 1 single bid — no competition | IQVIA Germany | complete |